Nabumetone and Viibryd drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nabumetone (nabumetone) and Viibryd (vilazodone hydrochloride). Common drug interactions include asthenia among females and psoriasis among males.
The phase IV clinical study analyzes what interactions people have when they take Nabumetone and Viibryd. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Nabumetone?
Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.
What is Viibryd?
Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.
29 people who take Nabumetone and Viibryd together, and have interactions are studied.

What are the common drug interactions of Nabumetone and Viibryd, by gender? *:
female:
- Asthenia (weakness)
- Blood iron decreased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Dyspnoea (difficult or laboured respiration)
- Peripheral swelling
- Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
- Red blood cell abnormality (abnormal red blood cells)
- Renal failure (kidney dysfunction)
- Weight increased
- Atelectasis (partial or complete collapse of the lung)
male:
- Psoriasis (immune-mediated disease that affects the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
What are the common drug interactions of Nabumetone and Viibryd, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Drug ineffective
30-39:
- Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Mania (a state of abnormally elevated or irritable mood)
- Neuropathy peripheral (surface nerve damage)
- Renal failure (kidney dysfunction)
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Chronic kidney disease
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
40-49:
- Eye infection
- Fatigue (feeling of tiredness)
- Hellp syndrome (life-threatening pregnancy complication)
- Influenza
- Migraine (headache)
- Pneumonia
- Renal failure (kidney dysfunction)
- Suicidal behaviour
- Tremor (trembling or shaking movements in one or more parts of your body)
- Apnoea (suspension of external breathing)
50-59:
- Psoriasis (immune-mediated disease that affects the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
60+:
- Carpal tunnel decompression
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Injection site bruising
- Injection site pain
- Oral pain
- Pruritus (severe itching of the skin)
- Trigger finger
What are the existing conditions these people have? *
- Immunodeficiency: 9 people, 31.03%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 27.59%
- Primary Immunodeficiency Syndrome: 6 people, 20.69%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 20.69%
- Stress And Anxiety: 4 people, 13.79%
- Pain: 4 people, 13.79%
- Sleep Disorder: 3 people, 10.34%
- Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 10.34%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.34%
- High Blood Pressure: 3 people, 10.34%
* Approximation only. Some reports may have incomplete information.
Do you take Nabumetone and Viibryd?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Nabumetone (9,554 reports)
- Viibryd (11,106 reports)
Browse all drug interactions of Nabumetone and Viibryd:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nabumetone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Viibryd:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nabumetone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viibryd and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on nabumetone and vilazodone hydrochloride (the active ingredients of Nabumetone and Viibryd, respectively), and Nabumetone and Viibryd (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ceftriaxone cause Cytokine Release Syndrome? - 6 seconds ago
- Kapvay vs. Bupropion Hydrochloride, side effect and effectiveness comparison - 11 seconds ago
- Drug interactions of Effexor Xr and Mestinon - 18 seconds ago
- Could Diclofenac cause Glossodynia? - 21 seconds ago
- Could Isovue-370 cause Nausea? - 22 seconds ago
- Could Sodium Bicarbonate cause Mitral Valve Incompetence? - 24 seconds ago
- Could Metformin cause Proctitis? - 26 seconds ago
- Drug interactions of Naprosyn and Zerit - 32 seconds ago
- Could Zantac 150 cause Chest Pain? - 44 seconds ago
- Drug interactions of Prinivil and Lorcet-Hd - 44 seconds ago